The invention relates to a technology for preparing compound
kidney inflammation tablets, which is characterized in that crushing red sage roots 337.5g into
fine powder, further mixing with baikal skullcap roots 202.5g, cattail
pollen 112.5g and
morning glory seeds 112.5g and crushing into
fine powder, then sieving, furthermore, uniformly mixing
motherwort fruits 450g,
astragalus roots 337.5g, Siberian solomonseal
rhizome 112.5g, poria cocos 202.5g, barbat skullcap 202.5g, doddor seeds 225g, gamene 112.5g, haw 337.5g, reed roots 202.5g, hizoma imperatae 225g, plantain seeds 225g, then adding water, and boiling the water for two hours through adding water by ten times at the first time, boiling for two hours through adding water by eight times at the second time, combining the boiled liquid, and filtering the boiled liquid, the filtering liquid is concentrated into thick paste whose relevant intensity is 1.35-1.39 (60 DEG C), adding the
fine powder which is formed through mixing and crushing the
scutellaria roots, the cattail
pollen and the
morning glory seeds, uniformly mixing, and
drying the fine
powder with 60 DEG C, crushing into fine
powder (passing through a 100-eyes screen), lastly adding crushed red sage root fine
powder and 1.0%
dextrin, uniformly mixing, preparing into granules by 85%
ethanol,
drying with the temperature of DEG C, namely obtaining one thousand tablets. The compound
kidney inflammation tablets produced by the technology have high effective component and good healing
efficacy.